Hereditary angioedema (HAE) typically presents in childhood. Large gaps remain in our understanding of the natural history of HAE during childhood. We examined age of onset, delay in diagnosis, androgen exposure, and their influence on ultimate disease severity in a large cohort of patients with HAE. Median age of first swelling was 11 years with a median age at diagnosis of 19 years. Earlier onset of symptoms correlated with longer delays in diagnosis (P < .001) and predicted a more severe disease course, including increased number of attacks per year (P = .0009) and hospital admissions (P = .009). Earlier age of onset also significantly correlated with increased perceived HAE severity (P = .0002), negative overall life impact (P < .0001), and use of anabolic androgen. Our observations highlight the importance of early HAE diagnosis and suggest the necessity of a disease management plan once the diagnosis has been made.
ZurawBL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359:1027-1036.
2.
WalfordHHZurawBL. Current update on cellular and molecular mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol. 2014;112:413-418.
3.
BorkKHardtJStaubach-RenzPWitzkeG. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:58-64.
4.
BorkKHardtJSchicketanzKHResselN. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med. 2003;163:1229-1235.
5.
BorkKResselN. Sudden upper airway obstruction in patients with hereditary angioedema. Transfus Apheresis Sci. 2003;29:235-238.
6.
BorkKBarnstedtSE. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc. 2003;134:1088-1094.
7.
BorkKBarnstedtSE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001;161:714-718.
8.
BorkKHardtJWitzkeG. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130:692-697.
9.
FarkasHVargaLSzeplakiGVisyBHarmatGBowenT. Management of hereditary angioedema in pediatric patients. Pediatrics. 2007;120:e713-e722.
10.
BorkKMengGStaubachPHardtJ. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119:267-274.
11.
ZurawBLBorkKBinkleyKE. Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc. 2012;33(suppl 1):S145-S156.
CaballeroT. Efficacy assessments in randomized controlled studies of acute therapy for hereditary angioedema. J Clin Immunol. 2012;32:1204-1212.
14.
FarkasHHarmatGFustGVargaLVisyB. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol. 2002;13:153-161.
15.
WahnVAbererWEberlW. Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies. Eur J Pediatr. 2012;171:1339-1348.
16.
BygumA. Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol. 2009;161:1153-1158.
17.
FrankMMGelfandJAAtkinsonJP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med. 1976;84:586-593.
18.
RocheOBlanchACaballeroTSastreNCallejoDLopez-TrascasaM. Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol. 2005;94:498-503.
19.
JollesSWilliamsPCarneE. A UK national audit of hereditary and acquired angioedema. Clin Exp Immunol. 2014;175:59-67.
20.
ZanichelliAMagerlMLonghurstHFabienVMaurerM. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe. Allergy Asthma Clin Immunol. 2013;9:29.
21.
PsarrosFKoutsostathisNFarmakiESpeletasMGGermenisAE. Hereditary angioedema in Greece: the first results of the Greek Hereditary Angioedema Registry. Int Arch Allergy Immunol. 2014;164:326-332.
22.
PappalardoECicardiMDuponchelC. Frequent de novo mutations and exon deletions in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol. 2000;106:1147-1154.
23.
NandaMKElenburgSBernsteinJAAssa’adAH. Clinical features of pediatric hereditary angioedema. J Allergy Clin Immunol Pract. 2015;3:392-395.
24.
PerriconeRPaneraiAESacerdoteP. High amounts of beta-endorphin in peripheral blood mononuclear cells from HANE patients. Immunopharmacology. 1991;22:21-26.
25.
ZotterZCsukaDSzaboE. The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. Orphanet J Rare Dis. 2014;9:44.
26.
ChristiansenSCBygumABanerjiA. Before and after, the impact of available on-demand treatment for HAE. Allergy Asthma Proc. 2015;36:145-150.
27.
SchneiderLHurewitzDWassermanR. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies. Pediatr Allergy Immunol. 2013;24:54-60.
28.
LumryWManningMEHurewitzDS. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children. J Pediatr. 2013;162:1017-1022.e1-2.
29.
FarkasHCsukaDZotterZVargaLFustG. Prophylactic therapy in children with hereditary angioedema. J Allergy Clin Immunol. 2013;131:579-582.e1-2.
30.
ReadNLimETarziMDHildick-SmithPBurnsSFidlerKJ. Paediatric hereditary angioedema: a survey of UK service provision and patient experience. Clin Exp Immunol. 2014;178:483-488.
